Life Sphere: Win the Race Against Time

Scientific Communications to Clinical Research: An Expert Perspective from Juliette Vandenbroucque

April 18, 2023 Acumen Analytics
Scientific Communications to Clinical Research: An Expert Perspective from Juliette Vandenbroucque
Life Sphere: Win the Race Against Time
More Info
Life Sphere: Win the Race Against Time
Scientific Communications to Clinical Research: An Expert Perspective from Juliette Vandenbroucque
Apr 18, 2023
Acumen Analytics

In this episode of the Life Sphere podcast, host Kathleen Brunner speaks with Juliette Vandenbroucque, a Senior Director of Business Development at a leading digital innovator in clinical research. With her extensive international experience spanning PR, scientific communications, global medical affairs, and clinical research, Juliette shares her unique perspective on the intersection of business development and innovation in the life sciences industry.

Juliette shares her insights into the challenges and opportunities of bringing new therapies to market in various therapeutic areas, including oncology, ophthalmology, neurology, and rare diseases. She also discusses her work with leading pharma companies and biotech startups, including her involvement in three IPOs, over 15 product launch strategies, and two new manufacturing site inaugurations.

Show Notes

In this episode of the Life Sphere podcast, host Kathleen Brunner speaks with Juliette Vandenbroucque, a Senior Director of Business Development at a leading digital innovator in clinical research. With her extensive international experience spanning PR, scientific communications, global medical affairs, and clinical research, Juliette shares her unique perspective on the intersection of business development and innovation in the life sciences industry.

Juliette shares her insights into the challenges and opportunities of bringing new therapies to market in various therapeutic areas, including oncology, ophthalmology, neurology, and rare diseases. She also discusses her work with leading pharma companies and biotech startups, including her involvement in three IPOs, over 15 product launch strategies, and two new manufacturing site inaugurations.